The Effect of Erythropoietin on Allogeneic Blood Requirement in Patients Undergoing Elective Liver Resection: A Model Simulation

Anesthesia and Analgesia

Volumn 98, Issue 4, 2004, Pages 921-926

  Lentschener, Claude ^a,b   Gomola, Alexandra ^a   Grabar, Sophie ^a   Soubrane, Olivier ^a   Dousset, Bertrand ^a   Massault, Pierre Philippe ^a   Penhoud, Catherine ^a   Ozier, Yves ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; COST BENEFIT ANALYSIS; ELECTIVE SURGERY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIMULATION;

EID: 1642543460     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000106861.92627.BB     Document Type: Article

References (21)

1. Mercuriali F, Inghilleri G. Proposal of an algorithm to help the choice of the best transfusion strategy. Curr Med Res Opin 1996;13:465-87.
2. Goodnough LT, Rudnick S, Price TH, et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 1989;321:1163-8.
3. Goldberg MA. Perioperative epoetin alfa increases red blood cell mass and reduces exposure to transfusions: results of randomized clinical trials. Semin Hematol 1997;34:41-7.
4. Leung JM, Weiskopf RB, Feiner J, et al. Electrocardiographic ST-segment changes during acute, severe isovolemic hemodilution in humans. Anesthesiology 2000;93:1004-10.
5. Shinozuka N, Koyama I, Arai T, et al. Autologous blood transfusion in patients with hepatocellular carcinoma undergoing hepatectomy. Am J Surg 2000;179:42-5.
6. Qvist N, Boesby S, Wolff B, Hansen CP. Recombinant human erythropoietin and hemoglobin concentration at operation and during the postoperative period: reduced need for blood transfusions in patients undergoing colorectal surgery-prospective double-blind placebo-controlled study. World J Surg 1999;23: 30-5.
7. Wei AC, Tung-Ping Poon R, Fan ST, Wong J. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg 2003;90:33-41.
8. Beguin Y. A risk-benefit assessment of epoetin in the management of anemia associated with cancer. Drug Saf 1998;19: 269-82.
9. Brecher ME, Monk T, Goodnough LT. A standardized method for calculating blood loss. Transfusion 1997;37:1070-4.
10. Canadian Orthopedic Perioperative Erythropoietin Study Group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 1993;341: 1227-32.
11. Bracey AW, Radovancevic R, Riggs SA, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion 1999;39: 1070-7.
12. Bryson G, Laupacis A, Wells G. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion: a meta-analysis-the international study of perioperative transfusion. Anesth Analg 1998;86:9-15.
13. Flesch BK, Neppert J. Transfusion-related acute lung injury caused by human leucocyte antigen class II antibody. Br J Haematol 2002;116:673-6.
14. Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA 2003;289:959-62.
15. Cohen DM, Norberto J, Cartabuke R, Ryu G. Severe anaphylactic reaction after primary exposure to aprotinin. Ann Thorac Surg 1999;67:837-8.
16. Gozzetti G, Mazziotti A, Grazzi GL, et al. Liver resection without blood transfusion. Br J Surg 1995;82:1105-10.
17. Narushima I, Kita T, Kubo K, et al. Highly enhanced permeability of blood-brain barrier induced by repeated administration of endothelin-1 in dogs and rats. Pharmacol Toxicol 2003;92:21-6.
18. Sejourne P, Poirier A, Meakins JL, et al. Effect of haemodilution on transfusion requirements in liver resection. Lancet 1989;2: 1380-2.
19. Matot I, Scheinin O, Jurim O, Eid A. Effectiveness of acute normovolemic hemodilution to minimize allogeneic blood transfusion in major liver resections. Anesthesiology 2002;97: 794-800.
20. Capraro L, Nuutinen L, Myllila G. Transfusion thresholds in common elective surgical procedures in Finland. Vox Sang 2000; 78:96-100.
21. Vamvakas EC. Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: the effects of the type of transfused red blood cell product and surgical setting. Transfus Med Rev 2002;16:304-14.